Sabby Management, LLC Outlook Therapeutics, Inc. Transaction History

Sabby Management, LLC

  • $2.93 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$0.56 - $1.41 $1.81 Million - $4.56 Million
-3,232,342 Closed
0 $0
Q1 2020

May 15, 2020
BUY
$0.51 - $1.08 $1.45 Million - $3.07 Million
2,843,406 Added 731.07%
3,232,342 $1.94 Million
Q4 2019

Feb 14, 2020
BUY
$0.53 - $1.59 $206,136 - $618,408
388,936 New
388,936 $229,000

Others Institutions Holding OTLK

# of Institutions
6
Shares Held
66.9K
Call Options Held
0
Put Options Held
0
View Full List

About Outlook Therapeutics, Inc.

OTLK Quotes by TradingView
  • Ticker OTLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,144,992
  • Market Cap $1.72B
  • Description
  • Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-relate...
More about OTLK
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email